cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV"
- PMID: 30259105
- PMCID: PMC6204285
- DOI: 10.1007/s00401-018-1913-0
cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV"
Comment in
-
The IMPACT of Molecular Grading of Gliomas on Contemporary Clinical Practice.Int J Radiat Oncol Biol Phys. 2020 Aug 1;107(5):859-862. doi: 10.1016/j.ijrobp.2020.05.043. Int J Radiat Oncol Biol Phys. 2020. PMID: 32698972 No abstract available.
References
-
- Arita H, Yamasaki K, Matsushita Y, Nakamura T, Shimokawa A, Takami H et al. (2016) A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas. Acta Neuropathol Commun 4: 79 Doi 10.1186/s40478-016-0351-2 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
